Aglaia identifies groundbreaking opportunities in cancer research and, in close partnerships with inventors and entrepreneurs, takes these opportunities to the next phase of technical and commercial development. In its commitment to create and build biomedical companies in the field of oncology, Aglaia does not only provide the financial means but also takes an active role in strategic and operational processes.

Adviseur energietransitie and schone technologie. Team Leader in vivo Pharmacology. Goodbye early-bird, hello regular fee! Merus, sponsor of the BioBusiness Summer School 2018. We welcome our new sponsor Merus, a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics.

Ensuring that your audiences understand the essence of complex scientific and medical concepts is key to the communication of science. Clear visuals combined with well-focussed text are essential for optimal communication. Scicomvisuals brings expertise in both.

Merus discovers and develops differentiated therapeutics aimed at substantially prolonging the lives of cancer patients. It is our strategy to use the power of bispecific antibody engineering and advanced screening technologies to develop biopharmaceuticals that engage the power of the immune system to kill tumor cells. There are currently no events scheduled. There are currently no items available.